{
    "nct_id": "NCT05357469",
    "official_title": "Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study",
    "inclusion_criteria": "1. - Both genders aged 15-39 years\n2. - Patients who have CIPN associated with at least moderate symptoms of pain (â‰¥4 on a 0-10 scale) or neuropathy.\n3. - Patients have had cancer and are not being actively treated,\n4. - Patients who speaks English and able to complete questionnaires by themselves or with help from parents and/or nurses. Written informed consent will be obtained from adults (aged 18-39 years) or from parents/guardians of adolescents (aged 15-17 years) and assent will be obtained from adolescents (aged 15-17 years) under an Institutional Review Board (IRB)-approved protocol.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. - Inability to walk or stand without assistance (need for ambulatory-assist devices)\n2. - Bone and/or central nervous system metastases that affect gait, walking and balance\n3. - History of other known or unknown causes of acute or chronic neuropathic and/or no neuropathic pain conditions.\n4. - Implanted intrathecal drug-delivery system or a spinal cord and/or peripheral nerve stimulator;\n\n   a) a metal implant such as a cardiac pacemaker, automatic defibrillator, aneurysm clips, vena cava clips, or skull plate.\n5. - History of epilepsy.\n6. - Skin damage at the site of electrode placement; and i) prior ST treatment; j) Patients on pain medications for other than CIPN.",
    "miscellaneous_criteria": ""
}